Amgen reported $2.71B in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
ALKERMES ALKS:US USD 136K 7.25M
Biogen BIIB:US USD 821M 53.8M
Bluebird Bio BLUE:US USD -76513000 16.99M
Coherus Biosciences CHRS:US USD -86650000 36.5M
Exelixis EXEL:US USD 92.04M 3.53M
Genmab GEN:DC DKK 3.27B 783M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
IONIS PHARMACEUT IONS:US USD -47000000 56M
Johnson & Johnson JNJ:US USD 8.07B 98M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Roche Holding ROG:VX 12.11B 2.43B
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Takeda 4502:JP JPY 64.55B 90.92B
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
YTE INCY:US USD 178.22M 131.36M